Robot takes the scalpel: new system tested for cancer surgeries

NCT ID NCT05696444

Ongoing Disease control Sponsor: Medtronic - MITG Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 16 times

Summary

This study looks at how safe and effective a new robotic surgery system (Medtronic Hugo) is for removing cancers of the prostate, bladder, or kidney. About 144 adults who need these surgeries will take part. The main goal is to see if the surgery can be completed without switching to another method, and to track any serious complications within 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

City of Hope

Duarte, California, 91010, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Duke Medical Center

Durham, North Carolina, 27710, United States
Mount Sinai

New York, New York, 10029, United States
Swedish Medical Center

Seattle, Washington, 98122, United States
University of Chiago

Chicago, Illinois, 60612, United States

Conditions

Explore the condition pages connected to this study.

BLADDER CANCER CONGENITAL ABNORMALITIES END STAGE RENAL DISEASE END STAGE RENAL DISEASE INTERSTITIAL CYSTITIS KIDNEY CANCER KIDNEY INJURY PELVIC TUMOR PROSTATE CANCER RENAL TUMOR